AACE Podcasts – Details, episodes & analysis

Join Dr. Steven Petak, Past President of AACE and ISCD and former Chief of Endocrinology at Houston Methodist Hospital, as he leads an in-depth conversation on Hypophosphatemia with Dr. Laila Tabatabai, Associate Professor of Clinical Medicine at Weill Cornell and metabolic bone specialist at Houston Methodist, and Dr. Basma Abdulhadi, Assistant Professor of Medicine at the University of Alabama at Birmingham and head of bone densitometry. Together, they discuss how to distinguish Hypophosphatemia from osteoporosis and osteomalacia, recognize key symptoms across ages, and apply a focused diagnostic workup. The discussion also highlights FGF23-mediated disorders, XLH, and current treatment approaches including burosumab, reinforcing a key reminder for clinicians to check phosphate levels to help prevent missed diagnoses. This episode is made possible through a sponsorship from Kyowa Kirin.

Kyowa Kirin was not involved in the content of the podcast.

Join Dr. Bahar Force, Endocrinologist, Medical Director of the Pituitary Center, and Associate Program Director of the Endocrinology Fellowship Program at Baylor College of Medicine, as she speaks with leading experts Dr. James Findling, Clinical Professor of Endocrinology at the Medical College of Wisconsin, and Dr. Ty Carroll, Visiting Professor of Endocrinology and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Wisconsin Madison, for a clinician-focused conversation on non-neoplastic hypercortisolism. Together, they discuss how common conditions can lead to cortisol elevations that resemble Cushing syndrome, the clinical patterns that raise concern for neoplastic hypercortisolism, and the growing role of the Desmopressin Stimulation Test in helping distinguish between the two. The episode also highlights emerging research, including insights from the Catalyst study and the potential role of cortisol-directed therapy.

In this episode, Dr. Jaime Almandoz, Associate Professor of Medicine at UT Southwestern, is joined by Dr. Robert F. Kushner, Professor of Medicine at Northwestern University and a leading authority in obesity medicine, to discuss the recent Lancet Diabetes & Endocrinology Commission report, “Definition and Diagnostic Criteria of Clinical Obesity.” The report introduces a new framework for defining clinical and preclinical obesity, aiming to move beyond the limitations of BMI. Dr. Kushner shares insights into the Commission’s global consensus process and how the updated definitions can transform care, reduce weight stigma, and support more targeted treatment. Don’t miss this timely conversation on the evolving future of obesity diagnosis and management.

Join 2025 Annual Meeting Chair, Cecilia Low Wang, MD, FACP, FACE, as she interviews Rachna Relwani, MD, Chair of the Environmental Endocrinology Topic Interest Group (TIG), and David C. Lieb, MD, FACP, FACE, Chair of the Artificial Intelligence and Clinical Endocrinology TIG. In this episode, you'll gain insight into how these TIGs are advancing critical conversations, fostering collaboration through AACE’s new Facebook Groups, and preparing for engaging meetups at the AACE Annual Meeting in Orlando, May 15–17. Whether you're passionate about environmental health or curious about the role of AI in clinical practice, this episode offers a dynamic preview of what’s ahead.

Join endocrine experts Lubaina S. Presswala, DO, FACOI, FACE; Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, FADCES; and Viral N. Shah, MD, FACE, as they explore the latest in continuous glucose monitors (CGMs) and automated insulin delivery (AID) systems for managing diabetes. In this episode, they discuss the practical applications of diabetes technology, patient selection, shared decision-making, and considerations for device use in specific populations, including athletes and pregnant individuals. This conversation provides valuable insights to help clinicians navigate device options and enhance outcomes across diverse patient scenarios.

Join Dr. David Lieb as he moderates a discussion with Dr. Jaydira Del Rivero, Chair of the MEN1 Consensus Statement Task Force, and Dr. Michelle Lundholm, Methodology Fellow, about the recently released 2025 AACE Consensus Statement on the Management of Multiple Endocrine Neoplasia, Type 1 (MEN1).

This episode covers:

1. AACE’s updated consensus statement methodology, including the new methodology fellow and patient representative roles
2. The role of surgical and non-surgical management strategies for patients with different types of MEN1-related tumors
3. The importance of patient values and preferences and risks/benefits of different screening modalities when determining appropriate screening frequencies for patients
4. Current gaps in the literature and future considerations for MEN1 research

Early detection and monitoring of Type 1 Diabetes (T1D) are crucial for improving patient outcomes and quality of life. Join clinical experts Lubaina S. Presswala, DO, FACOI, FACE; Jeff Unger, MD, FAAFP, FACE, DACD; and Javier Morales, MD, FACP, FACE, as they discuss the growing prevalence of T1D, the importance of autoantibody screening, the different stages of T1D, screening guidelines, patient counseling, and how early intervention can help delay progression and reduce complications. Support for this podcast is provided by Sanofi.

In this episode, join moderator Dr. David Lieb alongside esteemed panelists Dr. Shahnaz Sultan, Dr. Carol Peng, and Dr. Melanie Bird as they delve into the methodology behind the 2025 AACE Clinical Practice Guideline on Pharmacologic Management of Adults with Dyslipidemia.

Discover insights into:

• Why AACE adopted the GRADE framework and its implications for guideline development.
• The critical role of systematic reviews in creating evidence-based recommendations.
• How evidence is assessed using the GRADE approach.
• Practical takeaways for clinicians when implementing GRADE-informed guidelines in patient care.

Whether you’re a seasoned practitioner or new to the field, this discussion offers valuable perspectives on the evolution of evidence-based guideline development and its impact on clinical practice.

Join Dr. David Lieb as he moderates an engaging discussion with Dr. Shailendra Patel, Chair of the Dyslipidemia Guideline Task Force, and Dr. Kathleen Wyne, Vice Chair, about the recently released 2025 AACE Clinical Practice Guideline on Pharmacologic Management of Adults with Dyslipidemia.

This episode covers:

• What’s new or different in this update compared to the 2017 guideline.
• Surprising insights revealed during the evidence assessments and how they shaped the recommendations.
• Key considerations for clinicians as they integrate these updated recommendations into practice.
• Gaps in the literature and opportunities for future research.

Whether you’re familiar with the previous guideline or new to this topic, this conversation provides a comprehensive overview of the latest advancements in dyslipidemia management.

Join endocrine expert Cheryl Rosenfeld, DO, FACE, FACP, FSVM, ECNU, for a special AACE Podcast featuring her patient, Andree. Together, they explore Andree’s personal journey with thyroid disease and how the AACE Journey for Patients With Thyroid Disease website has been an invaluable resource, offering clear and accessible tools to navigate her thyroid condition with confidence. Don’t miss this inspiring discussion, brought to you with the support of AbbVie and Amgen Rare Disease.